Listed on GrantGunner. Last checked 14 Nov 2026.
About this grant
Five leading European cancer charities are joining forces in INTER-LOCAL, an international funding call aimed at accelerating clinical research into local treatment strategies for rare and hard-to-treat cancers. The call supports late-phase (phase 2/3) international clinical trials focusing on surgery or radiotherapy for rare and/or hard-to-treat cancers. Proposals must involve partners from at least three of the five funding countries (Belgium, Netherlands, Spain, Norway, Sweden).
Who can apply
Partners from at least three of the five funding countries (Belgium, Netherlands, Spain, Norway, Sweden); focus on rare cancers (incidence <6/100,000/year) and/or hard-to-treat cancers with 5-year survival <25%; core experimental intervention must be radiotherapy or surgery; late-phase (phase 2/3) international clinical trials.